Advertisement

Annals of Hematology

, Volume 96, Issue 6, pp 1041–1042 | Cite as

Causes of hospital admission in children and adults with transfusion-dependent thalassemia in Sardinia, 2000–2015

  • Raffaella OrigaEmail author
  • Franco Anni
  • Luca Mereu
  • Ilenia Follesa
  • Simona Campus
  • Carlo Dessì
  • Maria Loreta Foschini
  • GiovanBattista Leoni
  • Paolo Moi
  • Maddalena Morittu
  • Valeria Orecchia
  • Maria Perra
  • Antonietta Zappu
  • Rosa Anna Podda
Letter to the Editor

Dear Editor,

Since its opening in the 1980s, IIa Clinica Pediatrica at Ospedale Microcitemico “A.Cao” in Cagliari, Italy has been the reference for all types of medical conditions occurring in thalassemia major (TM) patients of all ages from South Sardinia. Between 2000 and 2015, 276 subjects out of 642 (43%) transfused at the same hospital were admitted once or more to IIa Clinica Pediatrica for a total of 690 admissions. The mean age at first hospital admission was 24.3 ± 10.9 years (range 0.2–51 years). At the start of the observation period, all patients followed up at the abovementioned center were on desferrioxamine, with the exception of 21 who were on deferiprone. In December 2015, 15.2% were on desferrioxamine, 25.2% were on deferiprone, 45.4% were on deferasirox, 13.3% were on desferrioxamine plus deferiprone, and 0.8% were on desferrioxamine plus deferasirox.

Over the entire period, the top five most prevalent causes of hospital admission were heart failure and/or...

Keywords

Heart Failure Hospital Admission Thalassemia Lymphadenitis Deferasirox 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

We would like to address special thanks to Luigia Prontu and Brunella Salis for the precious contribution in acquiring and classifying the hospital discharge forms.

Authorship

RO and IF designed the research study and wrote the paper. FA analyzed the data. LM gave a substantial contribute to the acquisition of data. MLF, GBL, MM, PM, MP, RAP, VO, CD, and SC contributed to acquiring, analyzing, and interpreting the data. All the authors revised the paper critically and approved the final version.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Dessì C, Leoni G, Moi P et al (2015) Thalassemia major between liver and heart: where we are now. Blood Cells Mol Dis 55:82–88CrossRefPubMedGoogle Scholar
  2. 2.
    Lesic B, Foulon J, Carniel E (2002) Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica. Antimicrob Agents Chemother 46:1741–1745CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Robins-Browne RM, Prpic JK (1983) Desferrioxamine and systemic yersiniosis. Lancet 2:1372CrossRefPubMedGoogle Scholar
  4. 4.
    Modell B, Khan M, Darlison M et al (2008) Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10:42CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Tanner MA, Galanello R, Dessi C et al (2008) Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson 10:12CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Tanner MA, Galanello R, Dessi C (2007) A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 115:1876–1884CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Raffaella Origa
    • 1
    • 2
    Email author
  • Franco Anni
    • 1
    • 2
  • Luca Mereu
    • 3
  • Ilenia Follesa
    • 1
    • 2
  • Simona Campus
    • 2
  • Carlo Dessì
    • 2
  • Maria Loreta Foschini
    • 2
  • GiovanBattista Leoni
    • 2
  • Paolo Moi
    • 1
    • 2
  • Maddalena Morittu
    • 2
  • Valeria Orecchia
    • 2
  • Maria Perra
    • 2
  • Antonietta Zappu
    • 2
  • Rosa Anna Podda
    • 2
    • 3
  1. 1.Department of Medical Sciences and Public HealthUniversity of CagliariCagliariItaly
  2. 2.Ospedale Pediatrico Microcitemico “A.Cao”– A.O. G.BrotzuCagliariItaly
  3. 3.University of NuoroNuoroItaly

Personalised recommendations